JPMorgan Chase & Co. Forecasts Strong Price Appreciation for Ventas (NYSE:VTR) Stock

by · The Cerbat Gem

Ventas (NYSE:VTR – Get Free Report) had its target price hoisted by investment analysts at JPMorgan Chase & Co. from $93.00 to $94.00 in a research report issued on Monday,Benzinga reports. The firm currently has an “overweight” rating on the real estate investment trust’s stock. JPMorgan Chase & Co.‘s price target would suggest a potential upside of 7.68% from the company’s previous close.

Other equities research analysts have also recently issued research reports about the company. BMO Capital Markets reiterated an “outperform” rating and set a $100.00 price objective on shares of Ventas in a research note on Monday, May 4th. Argus set a $88.00 price target on Ventas in a research report on Tuesday, February 10th. Scotiabank raised their price target on Ventas from $80.00 to $93.00 and gave the stock a “sector perform” rating in a research report on Monday, March 2nd. Evercore restated an “outperform” rating and issued a $95.00 price target on shares of Ventas in a research report on Wednesday, April 29th. Finally, KeyCorp raised their price objective on Ventas from $90.00 to $95.00 and gave the company an “overweight” rating in a research note on Thursday. Fourteen equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $93.56.

Read Our Latest Analysis on Ventas

Ventas Stock Up 0.0%

NYSE VTR traded up $0.04 during trading on Monday, hitting $87.30. The stock had a trading volume of 2,213,989 shares, compared to its average volume of 3,458,771. The company has a market capitalization of $42.44 billion, a PE ratio of 158.75, a P/E/G ratio of 2.15 and a beta of 0.74. The company’s 50-day moving average price is $84.81 and its two-hundred day moving average price is $80.56. The company has a debt-to-equity ratio of 0.95, a quick ratio of 0.25 and a current ratio of 0.25. Ventas has a 12 month low of $61.76 and a 12 month high of $88.76.

Ventas (NYSE:VTR – Get Free Report) last released its earnings results on Monday, April 27th. The real estate investment trust reported $0.11 EPS for the quarter, missing the consensus estimate of $0.12 by ($0.01). The firm had revenue of $1.65 billion during the quarter, compared to the consensus estimate of $1.59 billion. Ventas had a net margin of 4.25% and a return on equity of 2.09%. The company’s revenue was up 22.0% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.84 EPS. Ventas has set its FY 2026 guidance at 3.820-3.890 EPS. As a group, sell-side analysts forecast that Ventas will post 3.85 EPS for the current year.

Insiders Place Their Bets

In related news, EVP Carey S. Roberts sold 35,532 shares of the firm’s stock in a transaction dated Wednesday, February 11th. The stock was sold at an average price of $85.00, for a total value of $3,020,220.00. Following the sale, the executive vice president directly owned 72,755 shares of the company’s stock, valued at $6,184,175. This trade represents a 32.81% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. 0.53% of the stock is owned by company insiders.

Institutional Trading of Ventas

A number of hedge funds have recently made changes to their positions in VTR. Cloud Capital Management LLC bought a new position in shares of Ventas during the third quarter worth about $25,000. GoalVest Advisory LLC bought a new stake in Ventas in the fourth quarter worth approximately $26,000. Wiser Advisor Group LLC bought a new stake in Ventas in the third quarter worth approximately $27,000. IFC & Insurance Marketing Inc. bought a new stake in Ventas in the fourth quarter worth approximately $30,000. Finally, ORG Partners LLC increased its holdings in Ventas by 76.1% in the third quarter. ORG Partners LLC now owns 456 shares of the real estate investment trust’s stock worth $32,000 after purchasing an additional 197 shares in the last quarter. 94.18% of the stock is owned by institutional investors and hedge funds.

About Ventas

(Get Free Report)

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.

See Also